This is easily resolved by paying 100% of director salary as shares.
If they resist make it 50% in shares, and 50% in cash.
Strangely the above rarely happens!
Instead they want full 100% cash AND additional freebies, disguised as "performance shares", just for meeting rudimentary 'milestones' = aka, just for doing their job.
This is why BOD #1 had to be rolled.
The BGS/MLL SHs are VERY lucky they have a strong group of large shareholders that have the vested interests of ALL SHs at heart, and aren't afraid to call out directors when they are not aligned to the core benefit of realising equity gains for ALL SHs.
Let's see if our current BOD have gotten the message.....
GLTAH
- Forums
- ASX - By Stock
- FFX
- Interview with Chris Evans, MD Mali Lithium Ltd
Interview with Chris Evans, MD Mali Lithium Ltd, page-12
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add FFX (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online